Compared to the frequency of mutations in cancer-free controls from our previous studies, we observed statistically significant associations for PALB2 (OR = 11.66 p < 0.001) and for CHEK2 truncating mutations (OR = 2.93; p = 0.02) (Table 3). This evidence concerns the gene CHEK2 and cancer.